1. Home
  2. NXL vs FCUV Comparison

NXL vs FCUV Comparison

Compare NXL & FCUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXL
  • FCUV
  • Stock Information
  • Founded
  • NXL 2010
  • FCUV 2012
  • Country
  • NXL United States
  • FCUV United States
  • Employees
  • NXL N/A
  • FCUV N/A
  • Industry
  • NXL Medical Specialities
  • FCUV Industrial Machinery/Components
  • Sector
  • NXL Health Care
  • FCUV Industrials
  • Exchange
  • NXL Nasdaq
  • FCUV Nasdaq
  • Market Cap
  • NXL 17.8M
  • FCUV 15.9M
  • IPO Year
  • NXL 2022
  • FCUV N/A
  • Fundamental
  • Price
  • NXL $0.93
  • FCUV $4.26
  • Analyst Decision
  • NXL Strong Buy
  • FCUV
  • Analyst Count
  • NXL 1
  • FCUV 0
  • Target Price
  • NXL $5.00
  • FCUV N/A
  • AVG Volume (30 Days)
  • NXL 191.8K
  • FCUV 39.6K
  • Earning Date
  • NXL 11-07-2025
  • FCUV 11-06-2025
  • Dividend Yield
  • NXL N/A
  • FCUV N/A
  • EPS Growth
  • NXL N/A
  • FCUV N/A
  • EPS
  • NXL N/A
  • FCUV N/A
  • Revenue
  • NXL $174,813.00
  • FCUV $432,983.00
  • Revenue This Year
  • NXL $38.28
  • FCUV N/A
  • Revenue Next Year
  • NXL $185.71
  • FCUV N/A
  • P/E Ratio
  • NXL N/A
  • FCUV N/A
  • Revenue Growth
  • NXL 16.42
  • FCUV 140.82
  • 52 Week Low
  • NXL $0.59
  • FCUV $1.80
  • 52 Week High
  • NXL $4.49
  • FCUV $10.90
  • Technical
  • Relative Strength Index (RSI)
  • NXL 52.06
  • FCUV 73.97
  • Support Level
  • NXL $0.86
  • FCUV $3.23
  • Resistance Level
  • NXL $0.97
  • FCUV $3.34
  • Average True Range (ATR)
  • NXL 0.08
  • FCUV 0.38
  • MACD
  • NXL 0.00
  • FCUV 0.08
  • Stochastic Oscillator
  • NXL 48.80
  • FCUV 83.62

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About FCUV Focus Universal Inc.

Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.

Share on Social Networks: